Patent details

EP2292219 Title: Transdermal therapeutic system for the administration of rivastigmine

Basic Information

Publication number:
EP2292219
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP101790855
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Transdermal therapeutic system for the administration of rivastigmine
French Title of Invention:
Système thérapeutique transdermal pour l'administration de rivastigmine
German Title of Invention:
Transdermales therapeutisches System zur Verabreichung von Rivastigmin
SPC Number:

Dates

Filing date:
10/10/2006
Grant date:
12/06/2013
EP Publication Date:
12/06/2013
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
09/03/2011
EP B1 Publication Date:
12/06/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
10/10/2026
Renunciation date:
Revocation date:
18/07/2017
Annulment date:

Owner

From:
10/10/2006
 
 

Name:
LTS LOHMANN Therapie-Systeme AG
Address:
Lohmannstrasse 2, 56626 Andernach, Germany (DE)

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
19/06/2013
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
Theobald Frank
Address:
Germany (DE)

2

Name:
Platt Beatrix
Address:
Germany (DE)

3

Name:
Gargiulo Paul M.
Address:
United States (US)

4

Name:
Lane Roger Michael
Address:
United States (US)

5

Name:
Wall Bettina
Address:
Germany (DE)

Priority

Priority Number:
741511 P
Priority Date:
01/12/2005
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 9/70;

Publication

Bulletin

Bulletin Heading:
VRV
Bulletin edition number:
2018/02
Publication date:
15/01/2018
Description:
Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates

European Patent Bulletin

Issue number:
201801
Publication date:
03/01/2018
Description:
Revocation of the European patent

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
25/09/2017
Last Annual Fee Paid Number:
12
Last Annual Fee Paid Amount:
165 Euro
Payer:
MARKS & CLERK LLP
Filing date Document type Number of pages